Is Hologic (holx) stock a good buy?
According to the issued ratings of 9 analysts in the last year, the consensus rating for Hologic stock is Buy based on the current 3 hold ratings and 6 buy ratings for HOLX. The average twelve-month price target for Hologic is $83.57 with a high price target of $95.00 and a low price target of $75.00. Learn more on HOLX's analyst rating history.
Where can I buy shares of holx?
Shares of HOLX can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here.
What is the earnings release date of holx?
Hologic, Inc. (NASDAQ:HOLX) announced its earnings results on Wednesday, July, 28th. The medical equipment provider reported $1.33 earnings per share for the quarter, topping the Thomson Reuters' consensus estimate of $1.12 by $0.21.
What are analysts' 1 year price targets for Hologic's stock?
11 analysts have issued 1 year price objectives for Hologic's shares. Their predictions range from $38.28 to $62.00. On average, they expect Hologic's share price to reach $49.0255 in the next year. This suggests that the stock has a possible downside of 1.4%.
See more
Is HOLX stock a good buy?
Out of 8 analysts, 1 (12.5%) are recommending HOLX as a Strong Buy, 2 (25%) are recommending HOLX as a Buy, 5 (62.5%) are recommending HOLX as a Hold, 0 (0%) are recommending HOLX as a Sell, and 0 (0%) are recommending HOLX as a Strong Sell. What is HOLX's earnings growth forecast for 2022-2024?
How do I buy Hologic stock?
How to buy shares in HologicCompare share trading platforms. Use our comparison table to help you find a platform that fits you.Open your brokerage account. Complete an application with your details.Confirm your payment details. ... Research the stock. ... Purchase now or later. ... Check in on your investment.
How much is Hologic?
(NASDAQ: HOLX) Hologic stock price per share is $70.59 today (as of Jul 15, 2022).
Who are Hologic competitors?
Hologic's top competitors include Thales Microwave & Imaging Sub-Systems, Halton Healthcare, Integral Diagnostics, BioTelemetry and Qiagen. Hologic is a company that develops, manufactures, and supplies diagnostics products, medical imaging systems, and surgical products for women's health.
Is Hologic a Fortune 500 company?
Hologic | 2022 Fortune 500 | Fortune.
How big is Hologic?
With locations in over 15 countries and more than 5,500 employees globally, Hologic empowers healthy lives around the world.
Should I buy or sell Hologic stock right now?
9 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Hologic in the last twelve months. There are currently 4...
What is Hologic's stock price forecast for 2022?
9 equities research analysts have issued 1-year price targets for Hologic's shares. Their forecasts range from $75.00 to $95.00. On average, they p...
How has Hologic's stock performed in 2022?
Hologic's stock was trading at $76.56 on January 1st, 2022. Since then, HOLX shares have decreased by 6.3% and is now trading at $71.73. View the...
When is Hologic's next earnings date?
Hologic is scheduled to release its next quarterly earnings announcement on Wednesday, July 27th 2022. View our earnings forecast for Hologic .
How were Hologic's earnings last quarter?
Hologic, Inc. (NASDAQ:HOLX) released its earnings results on Wednesday, April, 27th. The medical equipment provider reported $2.07 earnings per sha...
What guidance has Hologic issued on next quarter's earnings?
Hologic issued an update on its FY22 earnings guidance on Wednesday, April, 27th. The company provided EPS guidance of $5.45 to $5.65 for the perio...
Who are Hologic's key executives?
Hologic's management team includes the following people: Mr. Stephen P. MacMillan , Chairman, CEO & Pres (Age 58, Pay $4.51M) ( LinkedIn Profile...
What is Steve MacMillan's approval rating as Hologic's CEO?
283 employees have rated Hologic CEO Steve MacMillan on Glassdoor.com . Steve MacMillan has an approval rating of 79% among Hologic's employees.
Who are some of Hologic's key competitors?
Some companies that are related to Hologic include Abbott Laboratories (ABT) , Medtronic (MDT) , Stryker (SYK) , Intuitive Surgical (ISRG) , B...
When is Hologic earnings call?
Who sold Holx stock?
How can I listen to Hologic's earnings call? Hologic will be holding an earnings conference call on Wednesday, July 28th at 4:30 PM Eastern . Interested parties can register for or listen to the call using this link or dial in at 719-457-0820 with passcode "5101679 PIN 3270".
Ideas
HOLX stock was sold by a variety of institutional investors in the last quarter, including Oregon Public Employees Retirement Fund, and North Star Investment Management Corp.. Company insiders that have sold Hologic company stock in the last year include Benjamin Jordan Cohn, Kevin R Thornal, and Sean S Daugherty.
Profile
Of all the stocks I scanned through, this is my favorite setup, short or long. I'm looking for HOLX to fall to old resistance (see weekly chart) at the trendline. This is also the 20ma on the monthly.
Key Earnings Data
Hologic, Inc. engages in the development, manufacture, and supply of diagnostics products, medical imaging systems, and surgical products dedicated to serve the healthcare needs of women. It operates through the following segments: Breast Health, Diagnostics, GYN Surgical, and Skeletal Health.
Quest Diagnostics (DGX) COVID Test Sales Aid Amid Price Woe
Zacks Earnings ESP (Expected Surprise Prediction) looks to find companies that have recently seen positive earnings estimate revision activity. The idea is that more recent information is, generally speaking, more accurate and can be a better predictor of the future, which can give investors an advantage in earnings season.
Hologic (NASDAQ:HOLX) Price Target and Consensus Rating
This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.
Analyst Ratings By Month
MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy).
Average Share Price and Price Target by Month
The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.
Hologic (NASDAQ:HOLX) Analyst Ratings Frequently Asked Questions
The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target.